AstraZeneca lupus drug fails to meet main goal in study

AstraZeneca's experimental drug anifrolumab failed to meet its main target in a late-stage clinical study treating patients with moderate to severe lupus, the British drugmaker said on Friday.

from Reuters: Health News https://ift.tt/2NzKeJL
via IFTTT